Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins

Bioorganic & Medicinal Chemistry
2016.0

Abstract

A library of nitric oxide-donor doxorubicins (NO-DOXOs) was synthesized by linking appropriate NO-donor moieties at C-14 position through an ester bridge. Their hydrolytic stability was evaluated. The intracellular accumulation and cytotoxicity of these novel NO-DOXOs were studied in DOXO-sensitive (HT29) and DOXO-resistant (HT29/dx) tumor-cells. Hydrolytically-stable compounds accumulated in HT29 and HT29/dx cells, thanks to the nitration of plasma-membrane efflux transporters. Surprisingly, no close correlation was found between intracellular accumulation and cytotoxicity. Only compounds with high mitochondria retention (due to nitration of mitochondrial efflux transporter) exert high cytotoxicity, through the activation of a mitochondrial-dependent apoptosis.

Knowledge Graph

Similar Paper

Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins
Bioorganic & Medicinal Chemistry 2016.0
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity
ACS Medicinal Chemistry Letters 2011.0
Doxorubicin-antioxidant co-drugs
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide
European Journal of Medicinal Chemistry 2019.0
Synthesis of cholesteryl doxorubicin and its anti-cancer activity
Bioorganic & Medicinal Chemistry Letters 2017.0
Mitochondria-Targeting Drug Oligomycin Blocked P-Glycoprotein Activity and Triggered Apoptosis in Doxorubicin-Resistant HepG2 Cells
Chemotherapy 2004.0
Conjugation with α-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin
Bioorganic & Medicinal Chemistry Letters 2009.0